{"title_page": "Charles Parks Richardson", "text_new": "[[File:Dr. Charles Richardson.jpg|thumb|Dr. Ricardson in March 2020]]\n'''Charles Parks Richardson''' (born July 5, 1971) is an American physician, philanthropist and visionary serial inventor of life-saving biotechnologies, medical devices and pharmaceuticals he is best known for the development of  the left-ventricular assist device (LVAD), the right-ventricular assist device (RVAD) and the total implantable, electric Total Artificial Heart (TAH). \n\nDr. Richardson was also honored in 2014 with a Global Medical Award for his groundbreaking product design and development. He is also the current Founder of Cleveland Diabetes Care which mission is to improve lives through innovations in the care for and treatment of diabetes with the ultimate goal of eliminating diabetes worldwide. {{Infobox person\n| name               = Dr. Charles Parks Richardson\n| birth_date         = July 5, 1971\n| education          = Winston-Salem State University,  Moore School of Business\n}}\n\n== Education ==\nRichardson received a B.S. degree in chemistry from [[Winston-Salem State University]] in [[Winston-Salem, North Carolina]]. He has an M.D. degree from Central America Health Sciences University School of Medicine. He holds an MBA from the University of South Carolina's [[Darla Moore School of Business|Moore School of Business]].<ref>{{cite news|title=Charles Parks Richardson, M.D., MBA|url=https://www.bloomberg.com/Research/stocks/private/person.asp?personId=215335923&privcapId=214647461 |website=bloomberg.com|accessdate=21 April 2016}}</ref>\n\n==Career==\nRichardson co-founded the company Cleveland Heart in January 2007. The company's medical technology focuses on total heart replacement and ventricular assist devices.<ref>{{cite web|title=Company Overview of Cleveland Heart, Inc.|url=http://www.investing.businessweek.wallst.com/research/stocks/private/person.asp?personId=215335923&privcapId=214647461&previousCapId=214647461&previousTitle=Cleveland%20Heart,%20Inc.|website=www.investing.businessweek.wallst.com|publisher=Business Week|accessdate=21 April 2016}}</ref>\n\nRichardson co-founded IntelliServices Inc. and was its CEO in January 2000. The company offers remote [[Electronic Medical Record|electronic medical records]]. Its product CareLink allowed medical providers to wireless monitor implanted medical devices via the Internet.<ref>{{cite web|title=Cleveland Heart Founder Dr. Charles Richardson Appointed to ReliantHeart Board of Directors|url=https://www.reuters.com/article/idUSnGNX6JK7kg+1d8+GNW20131114|website=www.Reuters.com|publisher=Reuters|accessdate=21 April 2016|language=en-US}}</ref> The company was sold and is now owned by Medtronic.<ref>{{cite web|title=Medtronic MyCareLink Connect|url=https://eu.mycarelinkconnect.com/PatientInfo/|website=eu.mycarelinkconnect.com|publisher=Medtronic|accessdate=21 April 2016}}</ref>\n\nIn 2004, Richardson founded TransWorld Med. He also serves as the company chairman.<ref>{{cite web|title=TransWorld Med Corporation|url=http://www.transworldmed.com/Management.htm|website=www.transworldmed.com|accessdate=22 April 2016}}</ref>\n\nIn 2007, Richardson founded TransWorld Kidney Corporation.<ref>{{cite web|title=TRANSWORLD KIDNEY CORPORATION LEGAL \u2013  NorthCarolinaCorps \u2013 Company Profiles of North Carolina|url=http://www.northcarolinacorps.com/corp/76689.html|website=www.northcarolinacorps.com|publisher=North Carolina Corporations}}</ref>\n\nRichardson is founder and chairman of Cleveland Heart, a partnership between [[Cleveland Clinic]] <nowiki/>and TransWorld Med to develop mechanical cardiac circulatory assist devices and artificial hearts.<ref>{{Cite news|url=http://www.bizjournals.com/charlotte/print-edition/2012/08/03/group-pumps-30-million-into-cleveland.html|title=Group pumps $30 million into Cleveland Heart plan - Charlotte Business Journal|newspaper=Charlotte Business Journal|access-date=2016-04-22}}</ref>\n\n==Inventions==\nRichardson created IntelliPhysician, a piece of software based on the same paperless principles as IntelliHeart, but handles a wider range of business-related processes, such as scheduling, accounts receivable, financial history, and billing. The software also processes insurance claim forms and gathers and stores patients\u2019 clinical data, including procedure and diagnosis history, email, hospital rounds information, and referring physician information.<ref>{{cite web|title=H-Quotient, Inc., Acquires Intelliservices, Inc.; More Than $0.40 Per Share Earnings Projected for 2003 |url=http://www.businesswire.com/news/home/20030314005170/en/H-Quotient-Acquires-Intelliservices-0.40-Share-Earnings-Projected|website=www.businesswire.com|publisher=Business Wire|accessdate=21 April 2016}}</ref> The company behind IntelliPhysician was acquired in 2006 by H-Quotient Inc. of Vienna, VA for $7.6m<ref>{{Cite web|url=https://www.wraltechwire.com/2002/12/16/sc-based-medical-software-firm-is-acquired-in-7-3m-deal/|title=SC-based Medical Software Firm Is Acquired in $7.3M Deal|date=2002-12-16|website=WRAL TechWire|language=en-US|access-date=2019-04-16}}</ref>.\n\nOne of TransWorld Heart Corp.'s inventions is the Soul Mate<ref>{{Cite web|url=http://www.implantable-device.com/2011/12/26/transworlds-soul-mate-implantable-heart-transplant-rejection-monitor/|title=TransWorld\u2019s Soul Mate Implantable Heart Transplant Rejection Monitor|last=Prutchi|first=David|date=2011-12-27|website=The World of Implantable Devices|access-date=2019-04-16}}</ref>. This product is an implantable device that can replace routine post-transplant heart [[biopsies]].<ref>{{cite news|last1=Thomas|first1=Jennifer|title=Startup finds its Soul Mate \u2013 Charlotte Business Journal|url=http://www.bizjournals.com/charlotte/stories/2009/04/20/story10.html?b=1240200000%255E1812860|newspaper=Charlotte Business Journal|accessdate=22 April 2016}}</ref> The Soul Mate was the first device to offer remote monitoring of congestive heat failure and allows physicians to track a patient's condition from home.<ref>{{Cite web|url=http://www.bizjournals.com/charlotte/print-edition/2012/03/23/cardiac-device-maker-to-launch-25m.html|title=Cardiac device maker TransWorld to launch $25M clinical trial - Charlotte Business Journal|website=Charlotte Business Journal|access-date=2016-04-22}}</ref>\n\nIn 2007 Richardson developed the SideKick, a system for real-time monitoring of a kidney after a transplant.<ref>{{cite web|title=TransWorld Kidney: SideKick|url=https://www.youtube.com/watch?v=_fhiz9xCFOk|website=YouTube|publisher=TransWorldKidney|accessdate=22 April 2016|date=22 January 2012}}</ref>\n\n== Other ==\n[[Cdiabetescare.com]]\n\n== References ==\n{{reflist}}\n\n{{Authority control}}\n\n{{DEFAULTSORT:Richardson, Charles}}\n[[Category:University of South Carolina alumni]]\n[[Category:Winston-Salem State University alumni]]\n[[Category:1971 births]]\n[[Category:Living people]]\n[[Category:American health care chief executives]]\n", "text_old": "'''Charles Parks Richardson''' (born July 5, 1971) is an American entrepreneur, doctor, and inventor<ref>{{Cite web|url=https://www.bloomberg.com/tosv2.html?vid=&uuid=60062ac0-605e-11e9-ba9c-2f59d2f24112&url=L3Jlc2VhcmNoL3N0b2Nrcy9wcml2YXRlL3BlcnNvbi5hc3A/cGVyc29uSWQ9MjE1MzM1OTIzJnByaXZjYXBJZD0yMTQ2NDc0NjE=|title=Bloomberg \u2013 Are you a robot?|website=www.bloomberg.com|access-date=2019-04-16}}</ref>.\n\n{{Infobox person\n| name               = Dr. Charles Parks Richardson\n| birth_date         = July 5, 1971\n| education          = Winston-Salem State University,  Moore School of Business\n}}\n\n== Education ==\nRichardson received a B.S. degree in chemistry from [[Winston-Salem State University]] in [[Winston-Salem, North Carolina]]. He has an M.D. degree from Central America Health Sciences University School of Medicine. He holds an MBA from the University of South Carolina's [[Darla Moore School of Business|Moore School of Business]].<ref>{{cite news|title=Charles Parks Richardson, M.D., MBA|url=https://www.bloomberg.com/Research/stocks/private/person.asp?personId=215335923&privcapId=214647461 |website=bloomberg.com|accessdate=21 April 2016}}</ref>\n\n==Career==\nRichardson co-founded the company Cleveland Heart in January 2007. The company's medical technology focuses on total heart replacement and ventricular assist devices.<ref>{{cite web|title=Company Overview of Cleveland Heart, Inc.|url=http://www.investing.businessweek.wallst.com/research/stocks/private/person.asp?personId=215335923&privcapId=214647461&previousCapId=214647461&previousTitle=Cleveland%20Heart,%20Inc.|website=www.investing.businessweek.wallst.com|publisher=Business Week|accessdate=21 April 2016}}</ref>\n\nRichardson co-founded IntelliServices Inc. and was its CEO in January 2000. The company offers remote [[Electronic Medical Record|electronic medical records]]. Its product CareLink allowed medical providers to wireless monitor implanted medical devices via the Internet.<ref>{{cite web|title=Cleveland Heart Founder Dr. Charles Richardson Appointed to ReliantHeart Board of Directors|url=https://www.reuters.com/article/idUSnGNX6JK7kg+1d8+GNW20131114|website=www.Reuters.com|publisher=Reuters|accessdate=21 April 2016|language=en-US}}</ref> The company was sold and is now owned by Medtronic.<ref>{{cite web|title=Medtronic MyCareLink Connect|url=https://eu.mycarelinkconnect.com/PatientInfo/|website=eu.mycarelinkconnect.com|publisher=Medtronic|accessdate=21 April 2016}}</ref>\n\nIn 2004, Richardson founded TransWorld Med. He also serves as the company chairman.<ref>{{cite web|title=TransWorld Med Corporation|url=http://www.transworldmed.com/Management.htm|website=www.transworldmed.com|accessdate=22 April 2016}}</ref>\n\nIn 2007, Richardson founded TransWorld Kidney Corporation.<ref>{{cite web|title=TRANSWORLD KIDNEY CORPORATION LEGAL \u2013  NorthCarolinaCorps \u2013 Company Profiles of North Carolina|url=http://www.northcarolinacorps.com/corp/76689.html|website=www.northcarolinacorps.com|publisher=North Carolina Corporations}}</ref>\n\nRichardson is founder and chairman of Cleveland Heart, a partnership between [[Cleveland Clinic]] <nowiki/>and TransWorld Med to develop mechanical cardiac circulatory assist devices and artificial hearts.<ref>{{Cite news|url=http://www.bizjournals.com/charlotte/print-edition/2012/08/03/group-pumps-30-million-into-cleveland.html|title=Group pumps $30 million into Cleveland Heart plan - Charlotte Business Journal|newspaper=Charlotte Business Journal|access-date=2016-04-22}}</ref>\n\n==Inventions==\nRichardson created IntelliPhysician, a piece of software based on the same paperless principles as IntelliHeart, but handles a wider range of business-related processes, such as scheduling, accounts receivable, financial history, and billing. The software also processes insurance claim forms and gathers and stores patients\u2019 clinical data, including procedure and diagnosis history, email, hospital rounds information, and referring physician information.<ref>{{cite web|title=H-Quotient, Inc., Acquires Intelliservices, Inc.; More Than $0.40 Per Share Earnings Projected for 2003 |url=http://www.businesswire.com/news/home/20030314005170/en/H-Quotient-Acquires-Intelliservices-0.40-Share-Earnings-Projected|website=www.businesswire.com|publisher=Business Wire|accessdate=21 April 2016}}</ref> The company behind IntelliPhysician was acquired in 2006 by H-Quotient Inc. of Vienna, VA for $7.6m<ref>{{Cite web|url=https://www.wraltechwire.com/2002/12/16/sc-based-medical-software-firm-is-acquired-in-7-3m-deal/|title=SC-based Medical Software Firm Is Acquired in $7.3M Deal|date=2002-12-16|website=WRAL TechWire|language=en-US|access-date=2019-04-16}}</ref>.\n\nOne of TransWorld Heart Corp.'s inventions is the Soul Mate<ref>{{Cite web|url=http://www.implantable-device.com/2011/12/26/transworlds-soul-mate-implantable-heart-transplant-rejection-monitor/|title=TransWorld\u2019s Soul Mate Implantable Heart Transplant Rejection Monitor|last=Prutchi|first=David|date=2011-12-27|website=The World of Implantable Devices|access-date=2019-04-16}}</ref>. This product is an implantable device that can replace routine post-transplant heart [[biopsies]].<ref>{{cite news|last1=Thomas|first1=Jennifer|title=Startup finds its Soul Mate \u2013 Charlotte Business Journal|url=http://www.bizjournals.com/charlotte/stories/2009/04/20/story10.html?b=1240200000%255E1812860|newspaper=Charlotte Business Journal|accessdate=22 April 2016}}</ref> The Soul Mate was the first device to offer remote monitoring of congestive heat failure and allows physicians to track a patient's condition from home.<ref>{{Cite web|url=http://www.bizjournals.com/charlotte/print-edition/2012/03/23/cardiac-device-maker-to-launch-25m.html|title=Cardiac device maker TransWorld to launch $25M clinical trial - Charlotte Business Journal|website=Charlotte Business Journal|access-date=2016-04-22}}</ref>\n\nIn 2007 Richardson developed the SideKick, a system for real-time monitoring of a kidney after a transplant.<ref>{{cite web|title=TransWorld Kidney: SideKick|url=https://www.youtube.com/watch?v=_fhiz9xCFOk|website=YouTube|publisher=TransWorldKidney|accessdate=22 April 2016|date=22 January 2012}}</ref>\n\n== Other ==\n[[Cdiabetescare.com]]\n\n== References ==\n{{reflist}}\n\n{{Authority control}}\n\n{{DEFAULTSORT:Richardson, Charles}}\n[[Category:University of South Carolina alumni]]\n[[Category:Winston-Salem State University alumni]]\n[[Category:1971 births]]\n[[Category:Living people]]\n[[Category:American health care chief executives]]\n", "name_user": "WikiCalvin24", "label": "safe", "comment": "Updated description and updated Job history", "url_page": "//en.wikipedia.org/wiki/Charles_Parks_Richardson"}
